Table 7 Comparison of BRS in various subgroups
Condition or therapy | No. (%) | BRS (ms/mmHg) | p value for interaction |
|---|---|---|---|
Hypertension | |||
 Yes | 68 (72) | 8.5 ± 4.4 | 0.056 |
 No | 26 (28) | 10.4 ± 4.6 | |
Hyperlipidemia | |||
 Yes | 83 (88) | 8.8 ± 4.4 | 0.424 |
 No | 11 (12) | 10.0 ± 5.8 | |
Smoking | |||
 Yes | 30 (32) | 9.9 ± 4.5 | 0.177 |
 No | 64 (68) | 8.5 ± 4.5 | |
Sulfonylurea use | |||
 Yes | 25 (27) | 7.1 ± 3.2 | 0.015 |
 No | 69 (73) | 9.7 ± 4.8 | |
Insulin use | |||
 Yes | 12 (13) | 9.7 ± 5.6 | 0.556 |
 No | 82 (87) | 8.9 ± 4.4 | |
RAAS inhibitor use | |||
 Yes | 34 (36) | 8.6 ± 4.8 | 0.284 |
 No | 60 (64) | 9.2 ± 4.4 | |
Calcium-channel blocker use | |||
 Yes | 32 (34) | 8.5 ± 4.8 | 0.258 |
 No | 62 (66) | 9.2 ± 4.4 | |
Beta-blocker use | |||
 Yes | 5 (5) | 8.4 ± 3.7 | 0.788 |
 No | 89 (95) | 9.0 ± 4.6 | |
Statin use | |||
 Yes | 28 (30) | 9.0 ± 5.0 | 0.138 |
 No | 66 (70) | 9.0 ± 4.4 | |